251 related articles for article (PubMed ID: 32265979)
1. Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer.
Di Z; Di M; Fu W; Tang Q; Liu Y; Lei P; Gu X; Liu T; Sun M
Front Genet; 2020; 11():192. PubMed ID: 32265979
[TBL] [Abstract][Full Text] [Related]
2. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
Sun M; Song H; Wang S; Zhang C; Zheng L; Chen F; Shi D; Chen Y; Yang C; Xiang Z; Liu Q; Wei C; Xiong B
J Hematol Oncol; 2017 Mar; 10(1):79. PubMed ID: 28356122
[TBL] [Abstract][Full Text] [Related]
3. A novel miRNA-based signature as predictive tool of survival outcome of colorectal cancer patients.
Zhao B; Wang W; Ye H; Wang J; Meng K; Yang T
Chem Biol Drug Des; 2023 Nov; 102(5):1024-1033. PubMed ID: 37532274
[TBL] [Abstract][Full Text] [Related]
4. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer.
Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B
Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis identifies low microRNA-215 expression as associated with a poor prognosis of patients with colorectal cancer through the IKβ-α signaling pathway.
Wang Z; Jiang X; Li Q; Jin Y; Liu X; Wang F; Mao Y; Hua D
Transl Cancer Res; 2020 Sep; 9(9):5233-5244. PubMed ID: 35117890
[TBL] [Abstract][Full Text] [Related]
6. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Pichler M; Ress AL; Winter E; Stiegelbauer V; Karbiener M; Schwarzenbacher D; Scheideler M; Ivan C; Jahn SW; Kiesslich T; Gerger A; Bauernhofer T; Calin GA; Hoefler G
Br J Cancer; 2014 Mar; 110(6):1614-21. PubMed ID: 24504363
[TBL] [Abstract][Full Text] [Related]
7. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
8. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
9. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SNHG10 upregulates BIN1 to suppress the tumorigenesis and epithelial-mesenchymal transition of epithelial ovarian cancer via sponging miR-200a-3p.
Lv W; Jia Y; Wang J; Duan Y; Wang X; Liu T; Hao S; Liu L
Cell Death Discov; 2022 Feb; 8(1):60. PubMed ID: 35149697
[TBL] [Abstract][Full Text] [Related]
11. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.
Wang Y; Huang L; Shan N; Ma H; Lu S; Chen X; Long H
Aging (Albany NY); 2021 Aug; 13(15):19894-19907. PubMed ID: 34388112
[TBL] [Abstract][Full Text] [Related]
12. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
[TBL] [Abstract][Full Text] [Related]
13. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.
Li J; Liang L; Xiu L; Zeng J; Zhu Y; An J; Wu L
Ann Transl Med; 2022 Jan; 10(2):125. PubMed ID: 35282101
[TBL] [Abstract][Full Text] [Related]
15. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
16. Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma.
Ma R; Zhao Y; He M; Zhao H; Zhang Y; Zhou S; Gao M; Di D; Wang J; Ding J; Wei M
Cancer Cell Int; 2019; 19():360. PubMed ID: 31892859
[TBL] [Abstract][Full Text] [Related]
17. Identification of Necroptosis-Related miRNA Signature as a Potential Predictive Biomarker for Prognosis and Immune Status in Colon Adenocarcinoma.
Ma X; Yang B; Dong H; Lin H; Wang W
J Oncol; 2022; 2022():9413562. PubMed ID: 36065304
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis Identified a 6-miRNA Prognostic Signature in Nasopharyngeal Carcinoma.
Chen Y; Wang Z; Li H; Li Y
Front Cell Dev Biol; 2021; 9():661105. PubMed ID: 34336826
[TBL] [Abstract][Full Text] [Related]
19. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.
Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K
Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595
[TBL] [Abstract][Full Text] [Related]
20. MiR-200a-3p promoted the malignant behaviors of ovarian cancer cells through regulating PCDH9.
Shi C; Yang Y; Zhang L; Yu J; Qin S; Xu H; Gao Y
Onco Targets Ther; 2019; 12():8329-8338. PubMed ID: 31632082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]